Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
Product Reset all filters
01 1Merislon
Betahistine Mesilate
Eisai
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 69
2022 Revenue in Millions : 62
Growth (%) : 26
Portfolio PDF
Product Web Link
Digital Content
Website
Corporate PDF